1. Vitamin D Related/Nuclear Receptor
  2. Estrogen Receptor/ERR
  3. Trioxifene mesylate

Trioxifene mesylate (LY133314) is an orally active and selective estrogen receptor (ER) modulator with human ERα IC50 of 203.49 nM and Ki of 20.84 nM. Trioxifene mesylate binds estradiol receptors, inhibits ERα-mediated gene expression, reduces circulating gonadotrophin levels. Trioxifene mesylate can be used for the research of advanced breast cancer and androgen-independent, metastatic prostatic adenocarcinoma.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Trioxifene mesylate

Trioxifene mesylate 構造式

CAS 番号 : 68307-81-3

容量 在庫状況
50 mg   お問い合わせ  
100 mg   お問い合わせ  
250 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

Other Forms of Trioxifene mesylate:

Top Publications Citing Use of Products

Estrogen Receptor/ERR アイソフォーム固有の製品をすべて表示:

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

Trioxifene mesylate (LY133314) is an orally active and selective estrogen receptor (ER) modulator with human ERα IC50 of 203.49 nM and Ki of 20.84 nM. Trioxifene mesylate binds estradiol receptors, inhibits ERα-mediated gene expression, reduces circulating gonadotrophin levels. Trioxifene mesylate can be used for the research of advanced breast cancer and androgen-independent, metastatic prostatic adenocarcinoma[1][2].

IC50 & Target

hERα

203.49 nM (IC50)

hERα

20.84 nM (Ki)

hERβ

1506.04 nM (IC50)

hERβ

144.85 nM (Ki)

体外実験

Trioxifene (0.3-10000 nM; 4 h) mesylate binds to purified human recombinant ERα with human ERα IC50 of 203.49 nM and Ki of 20.84 nM[2].
Trioxifene (0.1-10.0 μM; 24 h) mesylate weakly antagonizes ERα-mediated gene expression in PAIII rat prostatic adenocarcinoma cells but does not alter ERβ-mediated gene expression in these cells[2].
Trioxifene (7 days) mesylate inhibits the proliferation of PAIII rat prostatic adenocarcinoma cells in vitro with an IC50 of 4.6 μM[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

体内実験

Trioxifene mesylate exhibits significant antitumor activity in DMBA (HY-W011845)-induced rat mammary carcinoma[1].
Trioxifene (2.0-40.0 mg/kg; s.c.; daily; 28 days or continuously until death) mesylate significantly inhibits PAIII prostatic adenocarcinoma metastasis to lymph nodes and lungs, reduces male accessory sex organ weight, and extends mean survival to 64.44 days with continuous 40.0 mg/kg-day administration in male LW rats[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: LW (male, 110-125 g, injected s.c. with 1×106 PAIII prostatic adenocarcinoma cells in the dorsal tail)[2]
Dosage: 2.0 mg/kg; 4.0 mg/kg; 20.0 mg/kg; 40.0 mg/kg
Administration: s.c.; daily; 28 days or continuously until death
Result: Produced significant (P < 0.05) inhibition of PAIII metastasis, with maximum 86% reduction in gluteal lymph node weight, 88% reduction in iliac lymph node weight, and 98% reduction in pulmonary foci count at 40.0 mg/kg-day for 28 days.
Did not reduce primary tail tumor weight at any dose.
Induced dose-related, significant (P < 0.05) regression of male accessory sex organs, with maximum 76% reduction in normalized ventral prostate weight and 64% reduction in normalized seminal vesicle weight at 40.0 mg/kg-day for 28 days.
Caused significant (P < 0.05) dose-related decreases in final-to-initial body weight ratios, with a maximum 31% reduction at 40.0 mg/kg-day for 28 days.
Increased normalized testicular weights significantly (P < 0.05), though absolute testicular weights did not differ from controls.
Extended mean survival to 50.11 days in rats treated with 40.0 mg/kg-day for 28 days followed by vehicle, significantly longer than vehicle controls (41.78 days).
Extended mean survival to 64.44 days in rats treated continuously with 40.0 mg/kg-day until death, significantly longer than both vehicle controls and the 28-day treatment group.
分子量

549.68

分子式

C31H35NO6S

CAS 番号
SMILES

O=C(C1=C(C2=CC=C(OC)C=C2)CCC3=C1C=CC=C3)C4=CC=C(OCCN5CCCC5)C=C4.CS(=O)(O)=O

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション
参考文献
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
Trioxifene mesylate
製品番号:
HY-123664
数量:
MCE 日本正規代理店: